Cerebral Small Vessel Disease Imaging and Cognitive Outcomes

Cerebral small vessel disease (SVD) encompasses a spectrum of microvascular pathologies affecting arterioles, capillaries and venules in the brain. It is increasingly recognised as a major contributor to stroke, vascular cognitive impairment and dementia worldwide. Key imaging markers visible on magnetic resonance imaging include white matter hyperintensities, lacunar infarcts, cerebral microbleeds and enlarged perivascular spaces. Advances in quantitative and qualitative assessment have enabled the derivation of composite SVD scores, reflecting the total burden of microvascular injury and providing robust associations with cognitive decline, especially in domains of executive function and processing speed. Emerging approaches integrate high-resolution imaging with genetic and deep-learning methods to unravel early mechanisms, refine diagnostic criteria and improve risk stratification. Improved detection and harmonised definitions of SVD markers are poised to guide targeted interventions, inform clinical trials and ultimately mitigate the global burden of vascular cognitive impairment.

Research from Nature Portfolio

Genome-wide studies of perivascular space burden have identified multiple genetic loci implicated in early-life vascular development and extracellular matrix regulation. These findings link specific variants to perivascular space visibility in young adults and support a causal role for elevated blood pressure in perivascular enlargement and subsequent stroke risk. By elucidating molecular pathways, this work offers avenues for genetically informed drug prioritisation and highlights perivascular spaces as dynamic markers of cerebral microvascular health. In parallel, advances in deep convolutional neural networks have demonstrated the value of integrating anatomical location into automated segmentation of white matter hyperintensities. By combining multi-scale image patches with explicit spatial features, these models achieve human-comparable accuracy in lesion detection and volumetric quantification, enabling high-throughput analysis in large cohorts and fostering reproducible assessment of SVD progression.

Cerebral Small Vessel Disease Imaging and Cognitive Outcomes publication trend

The graph below shows the total number of articles in cerebral small vessel disease imaging and cognitive outcomes across all publications each year (not limited to Nature Index journals).

Technical terms

White matter hyperintensities (WMH): Areas of increased signal on T2-weighted MRI reflecting demyelination, gliosis or small vessel ischaemia.

Lacunes: Small, subcortical cavities resulting from healed small infarcts, typically 3–15 mm in diameter on MRI.

Cerebral microbleeds (CMBs): Small, round hypointense foci on susceptibility-weighted MRI indicative of chronic blood leakage.

Perivascular spaces (PVS): Fluid-filled spaces surrounding small blood vessels, visible as punctate or linear structures on T2-weighted images.

Diffusion tensor imaging (DTI): MRI technique that measures the directional diffusivity of water to assess microstructural integrity of white matter tracts.

Boston criteria version 2.0: Revised in-vivo MRI diagnostic framework for cerebral amyloid angiopathy, combining lobar haemorrhagic and white matter features to improve diagnostic accuracy.

References

1. Genomics of perivascular space burden unravels early mechanisms of cerebral small vessel disease. Nature Medicine (2023).
2. Location Sensitive Deep Convolutional Neural Networks for Segmentation of White Matter Hyperintensities. Scientific Reports (2017).
3. The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI–neuropathology diagnostic accuracy study. The Lancet Neurology (2022).
4. Cerebral small vessel disease and risk of incident stroke, dementia and depression, and all-cause mortality: A systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews (2018).
5. Total MRI load of cerebral small vessel disease and cognitive ability in older people. Neurobiology of Aging (2015).